Orientedly immobilised proteins as next generation platforms for interferon gamma release assays for the diagnosis of Mycobacterium tuberculosi
Lead Participant:
NPL MANAGEMENT LIMITED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| NPL MANAGEMENT LIMITED | £95,200 | £ 47,600 |
Participant |
||
| ORLA PROTEIN TECHNOLOGIES LIMITED | £58,500 | £ 43,875 |
| INNOVATE UK |
People |
ORCID iD |